Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Tonix Pharm Hld (TNXP)

1.13   -0.07 (-5.83%) 08-07 15:00
Open: 1.18 Pre. Close: 1.2
High: 1.19 Low: 1.12
Volume: 10,445,894 Market Cap: 142M
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, licensing, acquiring, and developing drugs and biologics to treat and prevent human disease and alleviate suffering in the United States. It is developing TNX-102 SL, a tablet containing cyclobenzaprine that is Phase III clinical trial for the treatment of fibromyalgia; and that is in Phase III clinical trial for the treatment of posttraumatic stress disorder, as well as TNX-102 SL for the treatment of agitation in Alzheimer's disease and alcohol use disorder.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.374 - 1.381 1.381 - 1.388
Low: 1.179 - 1.189 1.189 - 1.196
Close: 1.186 - 1.2 1.2 - 1.212

Technical analysis

as of: 2020-08-07 2:31:00 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.01     One year: 2.87
Support: Support1: 0.52    Support2: 0.43
Resistance: Resistance1: 1.72    Resistance2: 2.46
Pivot: 1.32
Moving Average: MA(5): 1.21     MA(20): 1.14
MA(100): 0.78     MA(250): 1.79
MACD: MACD(12,26): 0.12     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 24.34     %D(3): 31.21
RSI: RSI(14): 52.98
52-week: High: 5.90  Low: 0.39  Change(%): -74.7
Average Vol(K): 3-Month: 2561393  10-Days: 1718648

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TNXP has closed above bottom band by 21.2%. Bollinger Bands are 54.6% wider than normal. The large width of the bands suggest high volatility as compared to TNXP's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue.

Headline News

Thu, 06 Aug 2020
New Insight on Tonix Pharmaceuticals Holding Corp. (TNXP) - Stocks Register

Thu, 06 Aug 2020
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) 17.76% up over a week, Can The Stock Hit well above $1.52? - Marketing Sentinel

Thu, 06 Aug 2020
What Tonix Pharmaceuticals Holding Corp. (TNXP) Doesn’t Want You to Know - The News Heater

Thu, 30 Jul 2020
A Look At The Behavior Of Tonix Pharmaceuticals Holding Corp. (TNXP) Stock - Stocks Register

Thu, 30 Jul 2020
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Stock is Plummeting, Here is Why - The Oracle Dispatch

Thu, 30 Jul 2020
Tonix Pharmaceuticals to Participate in SNN Network Virtual Investor Conference - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 126
Shares Float (M) 52
% Held by Insiders 0.05
% Held by Institutions 7.00
Shares Short (K) 1,510
Shares Short P. Month (K) 514

Stock Financials

EPS -4.516
EPS Est This Year -3.020
EPS Est Next Year -2.470
Book Value (p.s.) 0.630
Profit Margin
Operating Margin
Return on Assets (ttm) -69.1
Return on Equity (ttm) -120.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.237
Qtrly Earnings Growth
Operating Cash Flow (M) -27
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -0.25
PEG Ratio
Price to Book value 1.81
Price to Sales
Price to Cash Flow -5.24

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.